Second quarter and YTD 2026 results showed strong revenue and membership growth, with Adjusted EPS up year-over-year. FY 2026 Adjusted EPS guidance is affirmed, but GAAP EPS guidance is revised lower due to Star Ratings headwinds. CenterWell and Medicaid expansion, as well as new contracts and acqu…
Second quarter and YTD 2026 results showed strong revenue and membership growth, with Adjusted EPS up year-over-year. FY 2026 Adjusted EPS guidance is affirmed, but GAAP EPS guidance is revised lower due to Star Ratings headwinds. CenterWell and Medicaid expansion, as well as new contracts and acquisitions, drove segment growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
